Robeco Institutional Asset Management B.V. Acquires 13,847 Shares of Molina Healthcare, Inc $MOH

Robeco Institutional Asset Management B.V. boosted its holdings in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 426.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,094 shares of the company's stock after buying an additional 13,847 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in Molina Healthcare were worth $5,092,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in MOH. Sivia Capital Partners LLC bought a new position in shares of Molina Healthcare in the first quarter worth approximately $240,000. Farther Finance Advisors LLC boosted its position in shares of Molina Healthcare by 100.3% in the first quarter. Farther Finance Advisors LLC now owns 659 shares of the company's stock worth $216,000 after purchasing an additional 330 shares during the period. Pallas Capital Advisors LLC boosted its position in shares of Molina Healthcare by 252.5% in the first quarter. Pallas Capital Advisors LLC now owns 7,259 shares of the company's stock worth $2,391,000 after purchasing an additional 5,200 shares during the period. Signet Financial Management LLC boosted its position in shares of Molina Healthcare by 12.0% in the first quarter. Signet Financial Management LLC now owns 6,002 shares of the company's stock worth $1,977,000 after purchasing an additional 645 shares during the period. Finally, Wealthcare Advisory Partners LLC bought a new position in shares of Molina Healthcare in the first quarter worth approximately $255,000. 98.50% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Ronna Romney sold 700 shares of the company's stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the sale, the director owned 17,131 shares of the company's stock, valued at $2,633,719.94. This represents a 3.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO James Woys purchased 10,000 shares of the firm's stock in a transaction that occurred on Monday, August 4th. The shares were acquired at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the purchase, the chief operating officer owned 74,331 shares of the company's stock, valued at $11,591,176.14. This represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.26% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on MOH shares. Barclays dropped their price target on shares of Molina Healthcare from $186.00 to $185.00 and set an "equal weight" rating for the company in a research report on Thursday, September 4th. Weiss Ratings reiterated a "sell (d+)" rating on shares of Molina Healthcare in a research report on Saturday, September 27th. Truist Financial restated a "hold" rating and set a $180.00 target price (down previously from $335.00) on shares of Molina Healthcare in a research report on Friday, July 25th. Wells Fargo & Company dropped their target price on shares of Molina Healthcare from $216.00 to $198.00 and set an "overweight" rating for the company in a research report on Friday, August 15th. Finally, Wall Street Zen lowered shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, June 29th. Three analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $225.18.

Molina Healthcare Price Performance

Shares of NYSE:MOH opened at $200.77 on Tuesday. The firm has a market cap of $10.88 billion, a price-to-earnings ratio of 9.90 and a beta of 0.55. The firm has a fifty day moving average price of $174.95 and a 200 day moving average price of $251.58. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. Molina Healthcare, Inc has a fifty-two week low of $151.95 and a fifty-two week high of $359.97.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The business had revenue of $11.43 billion for the quarter, compared to analysts' expectations of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. Molina Healthcare's revenue for the quarter was up 15.7% compared to the same quarter last year. During the same period in the previous year, the company earned $5.86 EPS. As a group, sell-side analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.